Brominated Flame Retardants vs Carrageenan: which is worse?

What is Brominated Flame Retardants?

Brominated flame retardants (BFRs) are a class of synthetic chemicals added to consumer products and materials to reduce flammability. They include polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), and others. While not direct food additives, they contaminate the food supply through environmental pathways and food packaging.

What is Carrageenan?

Carrageenan is a polysaccharide extracted from red seaweed (primarily Chondrus crispus and Eucheuma species). Used as a thickener, gelling agent, and stabilizer in food and personal care products. Food-grade carrageenan (undegraded) is different from degraded carrageenan (poligeenan), which is not food-grade and is a known inflammatory agent.

Documented risks

Brominated Flame Retardants: PBDEs and other BFRs are endocrine disruptors, neurodevelopmental toxicants, and probable carcinogens. They accumulate in human adipose tissue, breast milk, and blood. PBDEs were found in 100% of samples in multiple US population biomonitoring studies. US women have PBDE body burdens 10-100 times higher than European women, reflecting the US's historically heavy PBDE use before bans. Neurodevelopmental effects: multiple studies have associated prenatal PBDE exposure with lower IQ, attention deficits, and behavioral problems in children. A 2012 Environmental Health Perspectives study found inverse associations between PBDE cord blood levels and child IQ and behavioral outcomes. Thyroid disruption: BFRs structurally mimic thyroid hormones and compete with thyroid hormone binding proteins, disrupting the thyroid axis — critical for fetal brain development. Carcinogenicity: some PBDEs are associated with thyroid cancer risk in human studies. PBDEs enter the food supply primarily through fatty fish (salmon, tuna), meat, dairy, and some contaminated produce from biosolid-amended soils.

Carrageenan: Carrageenan safety has been disputed for decades, centering on the distinction between undegraded (food-grade, high-molecular-weight) carrageenan and degraded carrageenan (poligeenan). Poligeenan, produced by acid hydrolysis, is a known inflammatory and carcinogenic agent in animals. Food-grade carrageenan is a different molecule, but critics argue it can partially degrade in the acidic stomach environment. Dr. Joanne Tobacman at the University of Illinois has published multiple studies on carrageenan-induced inflammation. A 2001 paper in Environmental Health Perspectives (PMC1240867) demonstrated that food-grade carrageenan activates inflammatory signaling pathways (NF-κB) in human intestinal cells, inhibits insulin signaling, and causes intestinal injury in animal models. Her 2012 review in the Journal of Diabetes Research summarized multiple animal studies showing intestinal inflammation, ulcerations, and neoplasms. A 2017 review in Environmental Health Perspectives (Bhide et al.) found carrageenan activated NF-κB inflammatory pathways and could potentially exacerbate inflammatory bowel disease (IBD) in susceptible individuals. Major regulatory bodies including EFSA (comprehensive 2018 re-evaluation) and the WHO/FAO JECFA have consistently concluded that undegraded food-grade carrageenan does not cause cancer or significant harm at typical food use levels in healthy adults. However, the EU precautionary ban in infant formula (2018) acknowledged that infants' developing digestive systems may be more vulnerable to carrageenan's potential effects, and insufficient evidence of safety existed for this specific high-risk population. The USDA's removal of carrageenan from Organic certification (2018) reflected organic industry stakeholder concern despite the continued regulatory permission. Individuals with IBD or gut sensitivity may have reason to avoid carrageenan based on in vitro and animal data, even if the general population safety at food use levels is defended by EFSA and JECFA.